Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-P1944A |
Brand: | MCE |
CAS: | - |
MDL | - |
---|---|
Molecular Weight | 1664.85 |
Molecular Formula | C71H112F3N23O18S |
SMILES | - |
Apelin-13 TFA is an endogenous ligand for the G-protein coupled receptor angiotensin II protein J (APJ) , activating this G protein-coupled receptor with an EC 50 value of 0.37 nM. Apelin-13 TFA has vasodilatory and antihypertensive effects. Apelin-13 TFA also can be used for researching type 2 diabetes and metabolic syndrome [1] [2] [3] .
IC 50 : 0.37 nM (APJ) [1]
Apelin-13 (200 µg/kg; IP, daily for 4 weeks) improves cardiac function, improves insulin resistance, improves lipid metabolism, significantly decreases TNF-α and leptin on serum, induces the expression of Apelin-12 in serum and markedly elevates GLUT4 and p-AMPKα2 levels
[2]
.
Apelin-13 (10 and 100 μM; ICV, single dosage) increases the spontaneous discharges in the majority of pallidal neurons
[4]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Goto-Kakizaki (GK) rats (12 weeks old; 240-280 g; fed with a high-fat diet: 66.5% standard chow, 10% lard, 20% sucrose, 2.5% cholesterol and 1% pig bile salt) [2] |
Dosage: | 200 µg/kg |
Administration: | IP, daily for 4 weeks |
Result: | Significantly decreased heart rate; lowered the levels of fasting plasma glucose (FPG), fasting insulin (FINS) and homeostasis model assessment for insulin resistancey (HOMA-IR); decreased serum levels of total cholesterol (TC), triglyceride (TG) and low density lipoprotein-cholesterol (LDL-C) and increased high density lipoprotein-cholesterol (HDL-C); decreased NO level, cNOS activity, TNF-α and leptin in serum; induced the expression of Apelin-12. |
Animal Model: | Adult Wistar rats (SPF, 8-10 weeks, 240-280 g) [4] |
Dosage: | 10 and 100 μM |
Administration: | ICV, single dosage |
Result: | Increased the spontaneous discharges in the majority of pallidal neurons. |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT01590108 | Imperial College London |
Idiopathic Pulmonary Arterial Hypertension
|
March 2012 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
Sealed storage, away from moisture
Powder | -80°C | 2 years |
---|---|---|
-20°C | 1 year |
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
H 2 O : 50 mg/mL ( 30.03 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 0.6007 mL | 3.0033 mL | 6.0065 mL |
5 mM | 0.1201 mL | 0.6007 mL | 1.2013 mL |
10 mM | 0.0601 mL | 0.3003 mL | 0.6007 mL |
Add each solvent one by one: PBS
Solubility: 100 mg/mL (60.07 mM); Clear solution; Need ultrasonic
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.